(Press-News.org) With every bite of food we take, our intestinal immune system must make a big decision. Tasked with defending us from foreign pathogens, these exquisitely sensitive cells somehow distinguish friend from foe—destroying invaders while tolerating food and helpful bacteria. How the gut separates the good from the bad has long puzzled scientists.
Now, new research identifies specific gut cell types that communicate with T cells—prompting them to tolerate, attack, or simply ignore—and explains how these opposing responses are triggered. The findings, published in Science, give scientists a new understanding of how the intestinal immune system keeps the gut in balance, and may ultimately shed light on the root causes and mechanisms of food allergies and intestinal diseases.
“The big question is, how do we survive eating?” says lead author Maria C.C. Canesso, a postdoctoral fellow in the laboratories of Daniel Mucida and Gabriel D. Victora. “Why do our bodies normally tolerate food, and what goes wrong when we develop food allergies?”
Gut decisions
The intestinal immune system is complicated machinery. Tolerance to food begins with antigen presenting cells, or APCs, instructing T cells to stand down. This signal gives rise to pTregs, a special type of T cell that calms the immune response to food particles, and kicks off a cascade of activity involving additional immune cells that reinforce the message. But without knowing which specific APCs run the show, it’s difficult to tease out the ins and outs of the body’s eventual tolerance to food and intolerance to pathogens.
“There are so many types of antigen-presenting cells,” Canesso says. “Pinpointing which ones are doing what is a longstanding technical challenge.”
She began exploring this conundrum as a PhD student in the Mucida lab, which focuses on how the intestine balances defense with tolerance. During her postdoc, Canesso also joined the Victora lab, which developed a technology known as LIPSTIC that helps scientists catalogue cell-to-cell interactions, particularly among immune cells.
“The technological advances made by the Victora lab allowed us to understand immune cell dynamics that would not have been possible using existing tools,” says Mucida, head of the Laboratory of Mucosal Immunology.
After optimizing LIPSTIC for the task, Canesso and colleagues succeeded in pinpointing those APCs that promote tolerance—a process primarily handled by two types: cDC1s and Rorγt+ APCs. These cells capture dietary antigens from ingested food and present them to T cells, giving rise to the pTregs that ensure food tolerance.
“When we first developed LIPSTIC, we were aiming to specifically measure the interactions between B and T cells that promote antibody responses to vaccines,” says Victora, head of the Laboratory of Lymphocyte Dynamics. “It was to Maria’s credit that she was able to adapt this to settings so different from those it was originally intended for.”
They also uncovered how infections of the intestines can cause interference, demonstrating in mice that the parasitic worm Strongyloides venezuelensis shifts the balance away from tolerance promoting APCs and toward those that promote inflammation. Indeed, mice infected with this worm during a first exposure to a dietary protein display reduced tolerance towards this protein, and signs of allergy when challenged.
Finally, the team characterized the molecular signals underpinning these immune shifts, identifying key cytokines and pathways that influence how APCs present antigens and modulate immune responses. For example, the infection induced a surge in pro-inflammatory cytokines such as IL-6 and IL-12, which have been shown to nudge APC activity toward inflammatory outcomes. This inflammatory environment appears to override the immune system’s tolerance mechanisms. “The worm infection induces this an expansion of non-tolerogenic APCs that help deal with the infection, outnumbering the tolerance-related APCs,” Canesso says.
From food to food allergies
Together, the findings illuminate how the immune system maintains food tolerance and, in the case of parasitic infections, highlights the specific immune mechanisms that can go awry. “It’s important to note that our findings do not suggest that worm infections trigger food allergies,” clarifies Mucida, head of the Laboratory of Mucosal Immunology. “They reduce tolerance mechanisms while the immune response focuses on dealing with the worms.”
While these findings aren’t directly relevant to food allergies, they do lay some groundwork for further investigation into food intolerance. “If food allergies are derived from dysregulation on intestinal APCs inducing tolerance and protective responses to infections, perhaps we could one day modulate those APCs specifically to prevent food allergies,” Canesso says.
Next up, Canesso plans to shift her focus toward early life, exploring how maternal-neonatal interactions shape food intolerance. “Most allergies develop early in life,” she says. “I want to focus on how breast milk and maternal exposure to dietary antigens may influence a baby’s immune system, potentially shaping their risk of developing food allergies.”
END
New clues to the mechanism behind food tolerance and allergies
2025-01-28
ELSE PRESS RELEASES FROM THIS DATE:
Leveraging artificial intelligence for vaccine development: A Ragon-MIT advancement in T cell epitope prediction
2025-01-28
Cambridge, Mass.— An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell vaccine candidates.
Ragon faculty member Gaurav Gaiha, MD, DPhil, and MIT Professor Regina Barzilay, PhD, AI lead of the Jameel Clinic for AI and Health, have published research in Nature Machine Intelligence introducing MUNIS—a deep learning tool designed to predict CD8+ T cell epitopes with unprecedented accuracy. This advancement has the potential to accelerate vaccine development against various ...
Moffitt Research advocates for routine brain MRI screening in asymptomatic late stage breast cancer patients
2025-01-28
TAMPA, Fla. (Jan. 28, 2025) — A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study, published in Neuro-Oncology, suggests that doctors may need to rethink current screening guidelines for detecting brain metastasis in patients without symptoms.
Researchers examined 101 asymptomatic patients diagnosed with stage 4 breast cancer, including triple-negative, HER2-positive and hormone receptor-positive/HER2-negative ...
More primary care physicians are affiliated with hospitals, leading to increased patient costs
2025-01-28
PROVIDENCE, R.I. [Brown University] — A study by researchers at the Brown University School of Public Health shows that nearly half of all primary care providers (PCPs) in the United States are affiliated with hospitals, while the number of PCPs affiliated with private equity firms is growing and concentrated in certain regional markets.
Compared with PCPs at independent practices, those affiliated with hospitals or private equity firms charged higher prices for the same services.
The findings were published in JAMA Health Forum.
Health care consolidation is a driving force behind ...
Can you really have it all? New study reveals how to succeed at work without sacrificing your free time
2025-01-28
New INFORMS Organization Science Study Key Takeaways:
Integrating work-related learning into leisure activities can enhance confidence, build new skills and support professional growth.
Leisure-work synergizing is most effective for individuals who prefer blending work and personal life rather than keeping them separate.
Overdoing leisure-work synergizing may lead to fatigue, emphasizing the importance of balance to maintain its benefits.
BALTIMORE, MD, January 28, 2025 – Could your favorite hobbies help you get ahead at work? New research published in the INFORMS journal Organization Science explores “leisure-work ...
Western Kenyan farmers favor restoring land with native trees. Yet barriers remain
2025-01-28
African nations have grand ambitions to green up landscapes with trees; the Kenyan government, for example, launched an initiative to plant 15 billion trees by 2032. The hope is that new trees could help fight desertification, create opportunities for livelihood diversification, support nutritional diets, restore biodiversity in highly degraded land and capture planet-heating carbon. Restoring lands using trees could empower millions whose livelihoods depend on working the land while generating multiple environmental and social benefits.
Yet tree planting projects often fall short because ...
Inherited gene elevates prostate cancer risk in affected families
2025-01-28
A study of men with a family history of prostate cancer has discovered an inherited form of prostate cancer.
The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to the Vanderbilt University Medical Center study published in JCO Precision Oncology.
This discovery was replicated in five independent study populations collectively encompassing one-half million patients from the U.S. and Europe, with the increased prostate cancer risk estimates ranging from two- to 12-fold, according to lead author Jeffrey Smith, MD, PhD, associate ...
Rice SynthX and MD Anderson team awarded Kleberg medical grant for brain metastasis research
2025-01-28
Rice University chemist and director of the university’s Synthesis X Center Han Xiao and cancer biologist Dihua Yu of The University of Texas MD Anderson Cancer Center have received a three-year, $1.5 million grant from the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation, allowing them to do further research on overcoming the blood-brain barrier (BBB) for the treatment of brain metastasis. This hurdle blocks most cancer therapies from reaching the brain, but the scientists’ innovative approach could transform the treatment of brain ...
Microbial therapy offers new hope for vitiligo patients
2025-01-28
‘Astonishing’ findings in mice suggest microbial product could restore skin pigmentation
Offers hope for a disease that affects all skin tones, but is more visible and severe in darker skin
Vitiligo affects 0.5% to 2% of the global population
Patients available for interviews upon request
CHICAGO --- A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new Northwestern University pre-clinical study in mice.
The findings could offer hope to millions affected by the autoimmune ...
Strategic corporate social responsibility can create social, economic value
2025-01-28
UNIVERSITY PARK, Pa. — Strategic corporate social responsibility (CSR) efforts that are directly related to a hospitality company’s core business operations and competencies can help companies create both social and business value, according to researchers in the Penn State School of Hospitality Management.
Led by Penn State Professor of Hospitality Management Seoki Lee, the research team developed a strategic framework to help hospitality companies optimize their CSR activities — like environmental and social initiatives — to obtain greater social and business value. The researchers published their ...
Researchers identify genetic ‘fingerprint’ to predict drug resistance in bacteria
2025-01-28
Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the World Health Organization estimates it could surpass cancer and heart disease as the leading cause of death as more bacteria develop defenses to the drugs designed to combat them.
Now Tulane University researchers have identified a unique genetic signature in bacteria that can predict their likelihood of developing antibiotic resistance, according to a new study published in Nature Communications. The findings could help researchers more quickly identify precision-based treatments that are more effective ...